default author photo

Smaranda Gliga

Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases

SCHOLARLY PAPERS

2

DOWNLOADS

283

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Early Combination Therapy of COVID-19 in High-Risk Patients

Number of pages: 22 Posted: 02 Aug 2023
Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD), Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Independent, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf, University Bonn, Heinrich Heine University Dusseldorf, University of Bonn - Department of Internal Medicine I, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, University of Bonn - Department of Internal Medicine I, University of Bonn, University of Cologne - Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Heinrich Heine University Dusseldorf
Downloads 145 (508,926)

Abstract:

Loading...

COVID-19, immunocompromised host, dual anti-SARS-CoV-2 therapies, combination therapy, prolonged viral shedding, individualized therapeutic approaches

2.

Longitudinal Analysis of Escape Mutations in SARS-CoV-2 Omicron Variants after Sotrovimab Use in Immunodeficient Patients

Number of pages: 23 Posted: 14 Jun 2022
Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Institute of Virology, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, University of Cologne - Institute of Virology, Heinrich Heine University Dusseldorf - Institute of Virology, Heinrich Heine University Dusseldorf - Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, University of Cologne - Institute of Virology, Heinrich Heine University Dusseldorf - Institute of Virology, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Dusseldorf - Clinic of Gastroenterology, Hepatology and Infectious Diseases and Independent
Downloads 138 (534,155)

Abstract:

Loading...

immunodeficiency, Omicron, SARS-CoV-2, BA.1, sotrovimab, escape mutations